Easton Pharmaceutica Financials
EAPH Stock | USD 0.0001 0.00 0.00% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 0.8 | 0.62 |
|
|
Investors should never underestimate Easton Pharmaceutica's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Easton Pharmaceutica's cash flow, debt, and profitability to make informed and accurate decisions about investing in Easton Pharmaceutica.
Net Income |
|
Easton | Select Account or Indicator |
Understanding current and past Easton Pharmaceutica Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Easton Pharmaceutica's financial statements are interrelated, with each one affecting the others. For example, an increase in Easton Pharmaceutica's assets may result in an increase in income on the income statement.
Easton Pharmaceutica Stock Summary
Easton Pharmaceutica competes with Medicure, and INC Research. Parallel Industries Inc. does not have significant operations. Parallel Industries Inc. was founded in 1997 and is headquartered in Toronto, Canada. Easton Pharmaceuticals is traded on OTC Exchange in the United States.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Instrument | USA Stock View All |
Exchange | OTCCE Exchange |
ISIN | US2777741057 |
Business Address | 111 Brockhouse Road, |
Sector | Pharmaceuticals |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.eastonpharma.com |
Phone | 647 362 5700 |
Currency | USD - US Dollar |
Easton Pharmaceutica Key Financial Ratios
Return On Equity | -0.0269 | ||||
Price To Sales | 0.06 X | ||||
Gross Profit | 201.4 K | ||||
Net Income | (188.54 K) | ||||
Debt To Equity | 0.43 % |
Easton Pharmaceutica Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 2.6M | 10.1M | 17.2M | 10.2M | 11.7M | 12.3M | |
Other Liab | 48.3K | 46.2K | 161.1K | 180.2K | 162.1K | 250.1K | |
Accounts Payable | 30.8K | 568.5K | 845.1K | 255.8K | 230.2K | 327.4K | |
Total Liab | 2.5M | 3.0M | 10.1M | 3.3M | 3.8M | 2.0M | |
Other Assets | 1.8M | 742.6K | 95.8K | 94.0K | 84.6K | 80.4K | |
Net Tangible Assets | (465.0K) | (1.1M) | (1.1M) | (1.0M) | (930.6K) | (884.0K) | |
Retained Earnings | (39.1M) | (39.2M) | (39.6M) | (39.8M) | (35.8M) | (37.6M) | |
Long Term Debt | 2.2M | 2.2M | 8.5M | 2.5M | 2.9M | 1.9M | |
Total Current Assets | 198K | 66.3K | 249.8K | 426.3K | 383.7K | 234.0K |
Easton Pharmaceutica Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Operating Income | 54.9K | (124.2K) | (323.2K) | (188.5K) | (216.8K) | (227.7K) | |
Ebit | (245.3K) | (124.2K) | (323.2K) | (188.5K) | (216.8K) | (227.7K) | |
Income Before Tax | (245.3K) | (169.2K) | (323.2K) | (188.5K) | (216.8K) | (227.7K) | |
Net Income | (245.3K) | (169.2K) | (323.2K) | (188.5K) | (216.8K) | (227.7K) |
Easton Pharmaceutica Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | (43.0) | 156.8K | 493.0K | 258K | 296.7K | 311.5K | |
Net Income | (245.3K) | (169.2K) | (323.2K) | (188.5K) | (216.8K) | (227.7K) | |
Change To Netincome | 10.9M | 163.2K | 434.5K | (267.8K) | (308.0K) | (292.6K) |
Easton Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Easton Pharmaceutica's current stock value. Our valuation model uses many indicators to compare Easton Pharmaceutica value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Easton Pharmaceutica competition to find correlations between indicators driving Easton Pharmaceutica's intrinsic value. More Info.Easton Pharmaceutica is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . As of now, Easton Pharmaceutica's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Easton Pharmaceutica's earnings, one of the primary drivers of an investment's value.Easton Pharmaceutica Systematic Risk
Easton Pharmaceutica's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Easton Pharmaceutica volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Easton Pharmaceutica correlated with the market. If Beta is less than 0 Easton Pharmaceutica generally moves in the opposite direction as compared to the market. If Easton Pharmaceutica Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Easton Pharmaceutica is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Easton Pharmaceutica is generally in the same direction as the market. If Beta > 1 Easton Pharmaceutica moves generally in the same direction as, but more than the movement of the benchmark.
About Easton Pharmaceutica Financials
What exactly are Easton Pharmaceutica Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Easton Pharmaceutica's income statement, its balance sheet, and the statement of cash flows. Potential Easton Pharmaceutica investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Easton Pharmaceutica investors may use each financial statement separately, they are all related. The changes in Easton Pharmaceutica's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Easton Pharmaceutica's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Today, most investors in Easton Pharmaceutica Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Easton Pharmaceutica's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Easton Pharmaceutica growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Complementary Tools for Easton Stock analysis
When running Easton Pharmaceutica's price analysis, check to measure Easton Pharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Easton Pharmaceutica is operating at the current time. Most of Easton Pharmaceutica's value examination focuses on studying past and present price action to predict the probability of Easton Pharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Easton Pharmaceutica's price. Additionally, you may evaluate how the addition of Easton Pharmaceutica to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |